Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea |
| |
| Authors: | Jeong Su Park Sue Shin Eui‐Chong Kim Ji Eun Kim Yong Beom Kim Sohee Oh Eun Youn Roh Jong Hyun Yoon |
| |
| Affiliation: | 1. Department of Laboratory Medicine, Seoul National University Bundang Hospital, Gyeonggi‐do, Korea;2. Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea;3. Department of Laboratory Medicine, Seoul National University Boramae Hospital, Seoul, Korea;4. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea;5. Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea;6. Department of Biostatistics, Seoul National University Boramae Hospital, Seoul, Korea |
| |
| Abstract: | Persistent human papillomavirus type 16 (HPV16) is the major risk factor for cervical cancer. HPV16 intratypic variants differ in their geographical distribution and oncogenic potential. This study aimed to analyze the distribution of HPV16 variants and their association with cervical lesion histopathology in Korean women. In total, 133 HPV16‐positive cervical samples from women admitted to Seoul National University Boramae Hospital were analyzed by sequencing E6, E7, and L1 genes and the long control region (LCR), and the variant distribution according to cervical lesion grade was determined. Isolates were grouped into a phylogenetic lineage, and A1‐3, A4, C, and D sublineages were detected in 54.1, 37.8, 0.7, and 7.4% of samples, respectively. The most commonly observed LCR variations were 7521G>A (91.5%), 7730A>C (59.6%), and 7842G>A (59.6%). Furthermore, A4 or D sublineage‐positive women had a higher risk for cervical cancer than women who were positive for A1–3. Among HPV phylogenetic clusters, A1–3 was the predominant sublineage, and within A1–3, the 350G polymorphism was highly frequent. These results differed from those of previous studies in Korea and other Asian countries. The findings suggest that cervical neoplasia incidence in HPV16‐infected patients could be affected by the distribution of HPV16 variants in the population. |
| |
| Keywords: | Human papillomavirus 16 variant cervical cancer cervical intraepithelial neoplasia case– control study |
|
|
